2014

DuPont Delivers 2Q 2013 Operating EPS of $1.28 Agriculture Sales Grew; Titanium Dioxide Volumes Up

WILMINGTON, Del., July 23, 2013 /PRNewswire/ -- DuPont today announced second quarter 2013 operating earnings per share (EPS) of $1.28, in line with previously announced guidance.  Prior-year second quarter operating earnings were $1.50 per share.  GAAP1 EPS from continuing operations was $1.10 versus $1.15 for the second quarter 2012.  Results reflect strong Agriculture sales, sequentially improving titanium dioxide volumes and lower Performance Chemicals earnings.  

Highlights

  • Net sales were $9.8 billion, 1 percent below the prior year, principally reflecting lower titanium dioxide pricing. Total company volume increased 1 percent with increases in Agriculture, Performance Chemicals, Performance Materials, and Safety & Protection.   Volume declined in Electronics & Communications and Nutrition & Health.
  • For the first half, Agriculture segment sales grew 11 percent driven by seed price gains and volume growth in corn seeds, insecticides and fungicides.  First half operating earnings grew 8 percent despite higher seed input costs pressuring margins.
  • Total segment operating earnings were $1.9 billion versus $2.2 billion in the prior year.  Performance Chemicals operating earnings were down $330 million (about $.27 per share) from peak levels last year, principally reflecting significantly lower titanium dioxide prices.  Titanium dioxide volumes increased 12 percent from second quarter 2012 and 18 percent from first quarter 2013.
  • Cost productivity gains and restructuring savings are on track to meet or exceed full-year targets.
  • The company continues to expect full-year operating earnings to be about $3.85 per share.

"Agriculture sales remained strong in the second quarter and titanium dioxide volume improved.  As expected, this was largely offset by a substantial decline in Performance Chemicals earnings from last year's peak levels," said DuPont Chair and CEO Ellen Kullman.  "We anticipate second half earnings will be significantly better than last year's second half.  We expect to deliver full-year earnings modestly above 2012 results, overcoming steep declines in the titanium dioxide market and economic headwinds in Europe and parts of Asia."

1Generally Accepted Accounting Principles (GAAP)


Global Consolidated Net Sales – 2nd Quarter
Second quarter 2013 sales were $9.8 billion, 1 percent below last year, reflecting 1 percent higher volume more than offset by lower local selling prices and negative currency impact.   The table below shows second quarter regional sales and variances versus second quarter 2012.



Three Months Ended June

30, 2013


Percentage Change Due to:

(Dollars in millions)


$


% Change


Local 

Price


Currency

Effect


Volume


U.S. & Canada


$      4,744


1


2


-


(1)


EMEA*


2,081


-


(3)


(2)


5


Asia Pacific


2,090


(8)


(6)


(2)


-


Latin America


929


7


(4)


(1)


12


























Total Consolidated Sales


$      9,844


(1)


(1)


(1)


1


























* Europe, Middle East & Africa










Segment Sales – 2nd Quarter

The table below shows second quarter 2013 segment sales with related variances versus the prior year.



Three Months Ended


Percentage Change 

(Dollars in millions)

June 30, 2013

Due to:


$


% Change


USD

Price


Volume


Portfolio/

Other

Agriculture

$     3,631


7


6


1


-

Electronics & Communications 

653


(18)


(6)


(12)


-

Industrial Biosciences

304


1


1


-


-

Nutrition & Health

865


(2)


2


(2)


(2)

Performance Chemicals

1,782


(9)


(15)


6


-

Performance Materials

1,670


(2)


(3)


2


(1)

Safety & Protection

1,017


3


(2)


5


-

Other

3


 nm 







Total segment sales

9,925









Elimination of transfers

(81)









Consolidated net sales

$     9,844









 


Operating Earnings – 2nd Quarter











 Change vs. 2012 

(Dollars in millions)


2Q13


2Q12


$


%

Agriculture 


$       941


$      947


$         (6)


-1%

Electronics & Communications


95


99


(4)


-4%

Industrial Biosciences


43


42


1


2%

Nutrition & Health


61


105


(44)


-42%

Performance Chemicals


264


594


(330)


-56%

Performance Materials


336


344


(8)


-2%

Safety & Protection


172


181


(9)


-5%

Other


(73)


(87)


14


nm



1,839


2,225


(386)


-17%

Pharmaceuticals 


18


16


2


13%

Total segment operating earnings (1)


1,857


2,241


(384)


-17%










Corporate expenses


(195)


(224)


29


-13%

Interest expense


(115)


(117)


2


-2%

Operating earnings before income taxes and exchange gains/losses


1,547


1,900


(353)


-19%

Provision for income taxes on operating earnings, excluding taxes
      on exchange gains/losses


(373)


(460)


87


nm

Net after-tax exchange gains (losses) (2)


19


(10)


29


nm

Net income attributable to noncontrolling interests


(4)


(9)


5


nm

Operating earnings  


$    1,189


$   1,421


$     (232)


-16%










Operating earnings per share


$      1.28


$     1.50


$    (0.22)


-15%










(1)  See Schedules B and C for listing of significant items and their impact by segment.  




(2)  See Schedule D for additional information on exchange gains and losses.



 

The following is a summary of business results for each of the company's reportable segments in the second quarter which compares the current period with the prior year.  References to selling price are on a U.S. dollar basis, including the impact of currency.

Agriculture – Operating earnings of $941 million declined 1 percent as higher seed input costs were mostly offset by sales growth.  Agriculture sales increased 7 percent primarily due to higher seed prices and insecticide and fungicide volumes.

First half operating earnings of $2.5 billion increased 8 percent, driven by seed price gains and volume growth in corn seeds, insecticides and fungicides, partially offset by higher seed input costs. 

Electronics & Communications – Operating earnings of $95 million declined $4 million due to lower sales volume in photovoltaic markets.  Share gains were more than offset by less materials per watt for photovoltaic modules and reduced selling prices, primarily from pass-through of lower metals prices.  These declines were largely offset by OLED licensing income of $20 million.

Industrial Biosciences – Operating earnings of $43 million were up 2 percent on higher sales for Sorona® polymer for carpeting, but were partially offset by lower enzyme demand for ethanol production and animal nutrition. 

Nutrition & Health Operating earnings of $61 million decreased $44 million primarily due to higher guar inventory costs, lower enablers product line volume, one-time costs associated with harmonizing systems and processes, and growth investments.  Volumes reflect both general market softness in Europe and Asia and unseasonably cool weather in North America and Europe.

Performance Chemicals – Operating earnings of $264 million were $330 million lower, due primarily to price declines in the titanium dioxide market.  Lower prices for refrigerants and fluoropolymers coupled with higher operating costs also contributed to lower operating earnings.  Titanium dioxide volume was up 12 percent from second quarter 2012 and 18 percent from first quarter 2013.

Performance Materials – Operating earnings of $336 million decreased 2 percent primarily due to lower selling prices, partially offset by higher volume.  Volume growth in automotive and packaging markets was partially offset by softness in electronics and industrial markets.  

Safety & Protection – Operating earnings of $172 million decreased $9 million as higher volume and productivity gains were offset by weaker sales mix and an unfavorable currency impact.  Higher volume reflects increased demand for U.S. ballistics military protection, protective garments and construction products.

Additional information is available on the DuPont Investor Center website at http://www.investors.dupont.com.

Outlook
As previously announced, the company continues to expect its full-year 2013 operating EPS to be about $3.85, overcoming increased currency headwinds and market challenges associated with a sluggish global economy.  The company further expects that approximately 60 percent of its second half 2013 operating EPS outlook of about $1.00 will be earned in the fourth quarter.  DuPont anticipates continuing agricultural growth in Latin America and a strong start to the North American season, combined with a gradual increase in demand for its industrial products.

Use of Non-GAAP Measures
Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company.  Such measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance.  Reconciliations of non-GAAP measures to GAAP are provided in schedules A, C and D.

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward-Looking Statements:  This news release contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates," "anticipates" or other words of similar meaning.  All statements that address expectations or projections about the future, including statements about the company's growth strategy, product development, regulatory approval, market position, anticipated benefits of acquisitions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward-looking statements.  Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized.  Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control.  Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; inability to protect and enforce the company's intellectual property rights; and integration of acquired businesses and completion of divestitures of underperforming or non-strategic assets or businesses.  The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.

 

E. I. du Pont de Nemours and Company
Consolidated Income Statements
(Dollars in millions, except per share amounts)

SCHEDULE A










Three Months Ended
June 30,


Six Months Ended
June 30,






2013


2012


2013


2012





Net sales

$           9,844


$            9,917


$         20,252


$          20,097





Other income, net(a)

159


291


251


305





Total

10,003


10,208


20,503


20,402

















Cost of goods sold 

6,057


5,844


12,250


11,779





Other operating charges (a)

941


1,246


1,853


2,127





Selling, general and administrative expenses

983


972


1,966


1,927





Research and development expense 

542


533


1,063


1,041





Interest expense 

115


117


232


231





Total

8,638


8,712


17,364


17,105

















Income from continuing operations before income taxes

1,365


1,496


3,139


3,297





Provision for income taxes on continuing operations (a)

335


397


722


789





Income from continuing operations after income taxes

1,030


1,099


2,417


2,508





Net income from discontinued operations after taxes

4


76


1,972


171

















Net income 

1,034


1,175


4,389


2,679

















Less:  Net income attributable to noncontrolling interests

4


9


11


21

















Net income attributable to DuPont   

$           1,030


$            1,166


$           4,378


$            2,658

















Basic earnings per share of common stock (b):












Basic earnings per share of common stock from continuing operations

$             1.11


$              1.16


$             2.59


$              2.66





Basic earnings per share of common stock from discontinued operations

-


0.08


2.13


0.18





Basic earnings per share of common stock

$             1.11


$              1.24


$             4.73


$              2.84

















Diluted earnings per share of common stock (b):












Diluted earnings per share of common stock from continuing operations

$             1.10


$              1.15


$             2.58


$              2.63





Diluted earnings per share of common stock from discontinued operations

-


0.08


2.12


0.18





Diluted earnings per share of common stock

$             1.11


$              1.23


$             4.69


$              2.81





























Dividends per share of common stock   

$             0.45


$              0.43


$             0.88


$              0.84

















Average number of shares outstanding used in earnings per share (EPS) calculation:












  Basic

922,684,000


934,057,000


925,500,000


933,982,000





  Diluted

929,480,000


942,832,000


932,311,000


943,533,000

















(a) See Schedule B for detail of significant items.












(b) The sum of the individual earnings per share amounts may not equal the total due to rounding.




































Reconciliation of Non-GAAP Measures
























Summary of Earnings Comparison













Three Months Ended
June 30,


Six Months Ended
June 30,


2013


2012


%

Change


2013


2012


%
Change

Income from continuing operations after income taxes (GAAP)

$           1,030


$            1,099


-6%


$            2,417


$      2,508


-4%

Less:  Significant items benefit (charge) included in income from












continuing operations after income taxes (per Schedule B)

(78)


(215)




(58)


(247)



Non-operating pension/OPEB costs included in income from 












continuing operations after income taxes 

(85)


(116)




(184)


(234)



Net income attributable to noncontrolling interest

4


9




11


21



Operating earnings 

$           1,189


$            1,421


-16%


$            2,648


$      2,968


-11%













EPS from continuing operations (GAAP)

$             1.10


$              1.15


-4%


$              2.58


$        2.63


-2%

Significant items benefit (charge) included in EPS (per Schedule B)

(0.08)


(0.23)




(0.06)


(0.26)



Non-operating pension/OPEB costs included in EPS

(0.10)


(0.12)




(0.20)


(0.25)



Operating EPS

$             1.28


$              1.50


-15%


$              2.84


$        3.14


-10%

























 

 

E. I. du Pont de Nemours and Company
Condensed Consolidated Balance Sheets
(Dollars in millions, except per share amounts)

SCHEDULE A (continued)





June 30, 

2013


December 31,
2012


Assets






Current assets






Cash and cash equivalents


$           6,685


$           4,284


Marketable securities


211


123


Accounts and notes receivable, net 


8,985


5,452


Inventories 


6,373


7,565


Prepaid expenses


196


204


Deferred income taxes 


787


613


Assets held for sale


-


3,076


Total current assets


23,237


21,317


Property, plant and equipment, net of accumulated depreciation
   (June 30, 2013 - $19,494; December 31, 2012 - $19,085)


12,698


12,741


Goodwill


4,561


4,616


Other intangible assets 


4,942


5,126


Investment in affiliates


1,143


1,163


Deferred income taxes 


3,864


3,936


Other assets


904


960


Total


$         51,349


$         49,859








Liabilities and Equity






Current liabilities






Accounts payable


$           3,613


$           4,853


Short-term borrowings and capital lease obligations 


3,315


1,275


Income taxes 


796


343


Other accrued liabilities


4,166


5,997


Liabilities related to assets held for sale


-


1,084


Total current liabilities


11,890


13,552


Long-term borrowings and capital lease obligations 


10,765


10,465


Other liabilities


14,443


14,687


Deferred income taxes


896


856


Total liabilities


37,994


39,560








Commitments and contingent liabilities 












Stockholders' equity






Preferred stock


237


237


Common stock, $0.30 par value; 1,800,000,000 shares authorized;
   Issued at June 30, 2013 - 1,010,299,000 ; December 31, 2012 - 1,020,057,000


303


306


Additional paid-in capital


10,870


10,655


Reinvested earnings


17,156


14,383


Accumulated other comprehensive loss 


(8,544)


(8,646)


Common stock held in treasury, at cost (87,041,000 shares
   at June 30, 2013 and December 31, 2012)


(6,727)


(6,727)


Total DuPont stockholders' equity


13,295


10,208


Noncontrolling interests


60


91


Total equity


13,355


10,299


Total


$         51,349


$         49,859


 

 

E. I. du Pont de Nemours and Company
Condensed Consolidated Statement of Cash Flows
(Dollars in millions)

SCHEDULE A (continued)



Six Months Ended
June 30,


Total Company

2013


2012







Net income

$          4,389


$          2,679


Adjustments to reconcile net income to cash used for operating activities:





Depreciation

644


702


Amortization

193


198


Contributions to pension plans

(176)


(692)


Gain on sale of business

(2,682)


-


Other operating charges and credits - net

185


314


Change in operating assets and liabilities - net

(5,184)


(4,318)


Cash used for operating activities

$        (2,631)


$        (1,117)







Investing activities





Purchases of property, plant and equipment

(757)


(696)


Investments in affiliates

(31)


(14)


Proceeds from sale of business

4,815


-


Proceeds from sales of assets - net 

88


166


Net (increase) decrease in short-term financial instruments

(99)


388


Forward exchange contract settlements

58


80


Other investing activities - net

8


(7)


Cash provided by (used for) investing activities

4,082


(83)







Financing activities





Dividends paid to stockholders

(823)


(788)


Net increase in borrowings

2,369


2,406


Repurchase of common stock

(1,000)


(400)


Proceeds from exercise of stock options

384


406


Payments for noncontrolling interest

-


(447)


Other financing activities - net

74


27


Cash provided by financing activities

1,004


1,204







Effect of exchange rate changes on cash

(149)


(84)







Increase (decrease) in cash and cash equivalents

2,306


(80)







Cash and cash equivalents at beginning of period

4,379


3,586







Cash and cash equivalents at end of period

$          6,685


$          3,506












Reconciliation of Non-GAAP Measure










Calculation of Free Cash Flow - Total Company






Six Months Ended
June 30,





2013


2012


Cash provided by (used for) operating activities

$        (2,631)


$        (1,117)


Purchases of property, plant and equipment

(757)


(696)


Free cash flow

$        (3,388)


$        (1,813)












 

 


E. I. du Pont de Nemours and Company
Schedule of Significant Items from Continuing Operations
(Dollars in millions, except per share amounts)

SCHEDULE B









SIGNIFICANT ITEMS FROM CONTINUING OPERATIONS

























Pre-tax


After-tax


($ Per Share)



2013


2012


2013


2012


2013


2012

1st Quarter












Customer claims charge (a)

$      (35)


$      (50)


$      (22)


$      (32)


$      (0.02)


$       (0.04)

Income tax items (b)

-


-


42


-


0.04


-

1st Quarter - Total

$      (35)


$      (50)


$        20


$      (32)


$        0.02


$       (0.04)














2nd Quarter












Customer claims charge (a)

$      (80)


$    (265)


$      (51)


$    (169)


$      (0.05)


$       (0.18)

Income tax items (c)

(11)


-


(27)


-


(0.03)


-

Litigation settlement (d)

-


(137)


-


(123)


-


(0.13)

Gain on sale of equity method investment (e)

-


122


-


77


-


0.08

2nd Quarter - Total

$      (91)


$    (280)


$      (78)


$    (215)


$      (0.08)


$       (0.23)














Year-to-date - Total (f)

$    (126)


$    (330)


$      (58)


$    (247)


$      (0.06)


$       (0.26)














(a)

Second and first quarter 2013 and second and first quarter 2012 included charges of $(80), $(35), $(265) and $(50), respectively, recorded in Other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis® herbicide, bringing the total charges to $(865) at June 30, 2013.  The company will continue to evaluate reported claim damage as additional information becomes available. It is reasonably possible that additional charges could result related to this matter and the company currently estimates that total charges could be about $900. The company has an applicable insurance program with a deductible equal to the first $100 of costs and expenses. The insurance program limits are $725 for costs and expenses in excess of the $100. The company has submitted and will continue to submit requests for payment to its insurance carriers for costs associated with this matter. The process of seeking insurance recovery is ongoing and the timing and outcome are uncertain. This matter relates to the Agriculture segment.














(b)

First quarter 2013 included a net tax benefit of $42 consisting of a $68 benefit for the 2013 extension of certain U.S business tax provisions offset by a ($26) charge related to the global distribution of Performance Coatings cash proceeds.














(c)

Second quarter 2013 includes a charge of ($11) in Other income, net related to interest on a prior year tax position.  Second quarter 2013 also includes a charge of ($49) associated with a change in accrual for a prior year tax position offset by a $33 benefit for an enacted tax law change.














(d)

Second quarter 2012 included a charge of ($137) recorded in Other operating charges primarily related to the company's settlement of litigation with Invista.  This matter relates to Other.  



(e)

Second quarter 2012 included a pre-tax gain of $122 recorded in Other income, net associated with the sale of an equity method investment in the Electronics & Communications segment.














(f)

Earnings per share for the year may not equal the sum of quarterly earnings per share due to changes in average share calculations.














 

E. I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)

SCHEDULE C











Three Months Ended
June 30,


Six Months Ended
June 30,

SEGMENT SALES (1)




2013


2012


2013


2012

Agriculture




$    3,631


$    3,388


$      8,300


$      7,468

Electronics & Communications




653


795


1,269


1,472

Industrial Biosciences




304


300


593


588

Nutrition & Health




865


885


1,733


1,693

Performance Chemicals




1,782


1,968


3,367


3,868

Performance Materials




1,670


1,699


3,229


3,299

Safety & Protection




1,017


986


1,924


1,927

Other




3


1


4


2

Total Segment sales




9,925


10,022


20,419


20,317












Elimination of transfers




(81)


(105)


(167)


(220)

Consolidated net sales




$    9,844


$    9,917


$    20,252


$    20,097























(1)   Sales for the reporting segments include transfers.





 

E. I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)

SCHEDULE C (continued)






Three Months Ended
June 30,


Six Months Ended
June 30,

INCOME/(LOSS) FROM CONTINUING OPERATIONS (GAAP)

2013


2012


2013


2012

Agriculture 

$       861


$      682


$    2,342


$   1,970

Electronics & Communications

95


221


144


280

Industrial Biosciences

43


42


84


81

Nutrition & Health

61


105


137


184

Performance Chemicals

264


594


515


1,165

Performance Materials

336


344


628


621

Safety & Protection

172


181


310


340

Pharmaceuticals 

18


16


22


43

Other

(73)


(224)


(164)


(300)

Total Segment PTOI

1,777


1,961


4,018


4,384









Corporate expenses

(206)


(224)


(420)


(475)

Interest expense

(115)


(117)


(232)


(231)

Non-operating pension/OPEB costs

(126)


(174)


(273)


(350)

Net exchange gains (losses) (1)

35


50


46


(31)

Income before income taxes from continuing operations  

$    1,365


$   1,496


$    3,139


$   3,297


















Three Months Ended
June 30,


Six Months Ended
June 30,

SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2)

2013


2012


2013


2012

Agriculture 

$       (80)


$    (265)


$     (115)


$    (315)

Electronics & Communications

-


122


-


122

Industrial Biosciences

-


-


-


-

Nutrition & Health

-


-


-


-

Performance Chemicals

-


-


-


-

Performance Materials

-


-


-


-

Safety & Protection

-


-


-


-

Pharmaceuticals 

-


-


-


-

Other

-


(137)


-


(137)

Total significant items by segment

(80)


(280)


(115)


(330)

Corporate expenses

(11)


-


(11)


-

Total significant items before income taxes

$       (91)


$    (280)


$     (126)


$    (330)










Three Months Ended
June 30,


Six Months Ended
June 30,

OPERATING EARNINGS

2013


2012


2013


2012

Agriculture 

$       941


$      947


$    2,457


$   2,285

Electronics & Communications

95


99


144


158

Industrial Biosciences

43


42


84


81

Nutrition & Health

61


105


137


184

Performance Chemicals

264


594


515


1,165

Performance Materials

336


344


628


621

Safety & Protection

172


181


310


340

Pharmaceuticals 

18


16


22


43

Other

(73)


(87)


(164)


(163)

Total segment operating earnings

1,857


2,241


4,133


4,714

Corporate expenses

(195)


(224)


(409)


(475)

Interest expense

(115)


(117)


(232)


(231)

Operating earnings before income taxes and exchange gains (losses)

1,547


1,900


3,492


4,008

Net exchange gains (losses) (1)

35


50


46


(31)

Operating earnings before income taxes

$    1,582


$   1,950


$    3,538


$   3,977









(1)  See Schedule D for additional information on exchange gains and losses.




(2)  See Schedule B for detail of significant items.













 

E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)

SCHEDULE D










Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements
























Three Months Ended
June 30,


Six Months Ended
June 30,







2013


2012


2013


2012














Income from continuing operations before income taxes


$           1,365


$         1,496


$           3,139


$           3,297

Add: Significant items before income taxes


91


280


126


330

Add: Non-operating pension/OPEB costs


126


174


273


350

Operating earnings before income taxes


$           1,582


$         1,950


$           3,538


$           3,977

Less: Net income attributable to noncontrolling interests


4


9


11


21

Add:  Interest expense 


115


117


232


231

Adjusted EBIT from operating earnings


1,693


2,058


3,759


4,187

Add: Depreciation and amortization 


404


417


837


844

Adjusted EBITDA from operating earnings


$           2,097


$         2,475


$           4,596


$           5,031



























Reconciliation of Operating Earnings Per Share (EPS) Outlook




The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings from continuing operations excluding significant items and non-operating pension/OPEB costs.
















Second Half


Year Ended December 31,









2013 Outlook


2013 Outlook


2012 Actual





Operating EPS

About $1.00


$             3.85


$           3.77


















Significant items










Tax items


-


0.02


-





Sale of an equity method investment

-


-


0.08





Customer claims charges

-


(0.08)


(0.39)





Restructuring charge/adjustments

-


-


(0.17)





Litigation settlement

-


-


(0.13)





Asset impairment charge

-


-


(0.19)





Sale of business

-


-


0.08
















Non-operating pension/OPEB costs - estimate

(0.21)


(0.41)


(0.46)


















Impact of LIFO accounting change

-


-


0.02


















EPS from continuing operations (GAAP)

About $0.79


$             3.38


$           2.61












































 

E. I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions)

SCHEDULE D (continued)






















Exchange Gains/Losses on Operating Earnings













The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in Other income, net and the related tax impact is recorded in Provision for (benefit from) income taxes on the Consolidated Income Statements. 




















Three Months Ended

June 30,


Six Months Ended 

June 30,







2013


2012


2013


2012

Subsidiary/Affiliate Monetary Position Gain (Loss)













Pre-tax exchange gains (losses) (includes equity affiliates)






$       (55)


$      (188)


$     (150)


$      (141)

Local tax benefits (expenses)






16


23


19


16

Net after-tax impact from subsidiary exchange gains (losses)






$       (39)


$      (165)


$     (131)


$      (125)














Hedging Program Gain (Loss)













Pre-tax exchange gains (losses)






$         90


$        238


$       196


$        110

Tax benefits (expenses)






(32)


(83)


(69)


(39)

Net after-tax impact from hedging program exchange gains (losses)






$         58


$        155


$       127


$          71














Total Exchange Gain (Loss)













Pre-tax exchange gains (losses)






$         35


$          50


$         46


$        (31)

Tax benefits (expenses)






(16)


(60)


(50)


(23)

Net after-tax exchange gains (losses) (1)






$         19


$        (10)


$         (4)


$        (54)














As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary/Affiliate Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."  














(1)  The above Net after-tax exchange gains (losses) excludes gains (losses) attributable to discontinued operations of $0 and $(20) for the three months ended June 30, 2013 and 2012, respectively, and $(5) and $(20) for the six months ended June 30, 2013 and 2012, respectively.


















Reconciliation of Base Income Tax Rate to Effective Income Tax Rate





Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), as defined above, significant items and non-operating pension/OPEB costs. 




















Three Months Ended

June 30,


Six Months Ended 

June 30,







2013


2012


2013


2012














Income from continuing operations before income taxes 






$    1,365


$     1,496


$    3,139


$     3,297

Add:   Significant items - (benefit) charge (2)






91


280


126


330

Non-operating pension/OPEB costs






126


174


273


350

Less:  Net exchange (losses) gains






35


50


46


(31)

Income from continuing operations before income taxes, significant items, exchange 








gains (losses), and non-operating pension/OPEB costs






$    1,547


$     1,900


$    3,492


$     4,008














Provision for income taxes on continuing operations






$       335


$        397


$       722


$        789

Add:  Tax benefits (expenses) on significant items






13


65


68


83

          Tax benefits (expenses) on non-operating pension/OPEB costs

41


58


89


116

          Tax benefits (expenses) on exchange gains/losses

(16)


(60)


(50)


(23)

Provision for income taxes on operating earnings, excluding exchange gains (losses)

$       373


$        460


$       829


$        965














Effective income tax rate






24.5%


26.5%


23.0%


23.9%

Significant items effect and non-operating pension/OPEB costs effect

0.1%


0.2%


1.8%


0.9%

Tax rate, from continuing operations, before significant items and non-operating pension/OPEB costs

24.6%


26.7%


24.8%


24.8%

Exchange gains (losses) effect






(0.5%)


(2.5%)


(1.1%)


(0.7%)

Base income tax rate from continuing operations






24.1%


24.2%


23.7%


24.1%














(2)  See Schedule B for detail of significant items. 





SOURCE DuPont



RELATED LINKS
http://www.dupont.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.